Latest news
FDA feedback supports new testing path for therapy in MS relapses - Multiple Sclerosis News TodayMultiple Sclerosis News Today · Thu, 06 Aug 2026 22:51:52 GMTOculis Reports Q2 2026 Financial Results and Provides Company Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTOculis Receives Positive FDA Feedback for Privosegtor Development in Acute Multiple Sclerosis Relapses - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 08:10:00 GMT